<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
  dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
  <?SourceDTD.Version 1.2?>
  <?ConverterInfo.XSLTName jats2jats3.xsl?>
  <?ConverterInfo.Version 1?>
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="iso-abbrev">Arch Pharm Pract</journal-id>
      <journal-id journal-id-type="publisher-id">archivepp.com</journal-id>
      <journal-id journal-id-type="publisher-id">Arch Pharm Pract</journal-id>
      <journal-title-group>
        <journal-title>Archives of Pharmacy Practice</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2320-5210</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">archivepp.com-1296</article-id>
      <article-id pub-id-type="doi">10.51847/5ojs70Ftj2</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Keeping Algorithmic Medication Advice Open to Challenge in Routine Pharmacy Care</article-title>
      </title-group>
                    <contrib-group>
                      <contrib contrib-type="author">
              <name>
                <surname>Kovács</surname>
                <given-names>Zsolt</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                                            <xref rid="cor1" ref-type="corresp" />
                          </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Szabo</surname>
                <given-names>Katalin</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Nagy</surname>
                <given-names>Gabor</given-names>
              </name>
                              <xref rid="aff2" ref-type="aff">2</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Toth</surname>
                <given-names>Eszter</given-names>
              </name>
                              <xref rid="aff3" ref-type="aff">3</xref>
                                        </contrib>
                  </contrib-group>
                  <aff id="aff1">
            <label>1</label>Department of Open-to-Challenge Medication Advice, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary.
          </aff>
                  <aff id="aff2">
            <label>2</label>Department of Algorithmic Accountability in Pharmacy, Faculty of Pharmacy, University of Debrecen, Debrecen, Hungary.
          </aff>
                  <aff id="aff3">
            <label>3</label>Department of Clinical Challenge and AI, Faculty of Pharmacy, University of Pécs, Pécs, Hungary.
          </aff>
                          <author-notes>
            <corresp id="cor1">
              <bold>Address for correspondence:</bold> Prof. Wael Abu Dayyih, Department of
              Pharmaceutical Chemistry, Faculty of Pharmacy, Mutah University, Al-Karak 61710, Jordan.
                              E-mail: <email xlink:href="zsolt.kovacs@semmelweis.hu">zsolt.kovacs@semmelweis.hu</email>
                          </corresp>
          </author-notes>
                    <pub-date pub-type="epub">
        <day>16</day>
        <month>08</month>
        <year>2026</year>
      </pub-date>
      <volume>17</volume>
      <issue>3</issue>
      <fpage>75</fpage>
      <lpage>83</lpage>
      <permissions>
        <copyright-statement>
          Copyright: &#x000a9; 2026 Archives of Pharmacy Practice
        </copyright-statement>
        <copyright-year>2026</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/"
            specific-use="textmining" content-type="ccbyncsalicense">
            https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
          <license-p>This is an open access journal, and articles are distributed under the terms of
            the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows
            others to remix, tweak, and build upon the work non-commercially, as long as appropriate
            credit is given and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>A<sc>BSTRACT</sc></title>
        <p>Algorithmic systems increasingly generate medication alerts, risk estimates, prioritizations, and treatment suggestions that can influence pharmacists, prescribers, patients, and organizations. Their safety cannot be secured solely through predictive performance, the presence of a professional reviewer, or the provision of a technical explanation. When advice is difficult to question, interrupt, reassess, or correct, it may acquire practical authority beyond its evidential strength. This article develops an original contestability framework for algorithmic medication advice in routine pharmacy care. Contestability is defined as the practical capacity of an affected or responsible person to obtain decision-relevant information, raise a challenge, activate a proportionate protective response, secure accountable review, and achieve correction or justified confirmation. The proposed framework connects six functions: registration of the advice object; access to reasons, evidence, alternatives, uncertainty, and limitations; human deliberation; challenge and escalation; correction or supersession; and organizational learning. Accountability, accessibility, equity, traceability, response time, and auditability operate as cross-cutting conditions. The framework distinguishes model output from medication decisions, explanation from justification, nominal oversight from meaningful review, and patient-level correction from system-level learning. Evaluation should assess whether contestability can be located, understood, initiated, answered, and closed under realistic workload and consequence conditions. Validation requires prospective pharmacy-workflow studies, patient and professional usability research, safety evaluation, equity analysis, external assessment, and longitudinal monitoring. Contestability is presented as a necessary governance capability rather than proof of algorithmic validity, clinical benefit, regulatory acceptability, or deployment readiness.</p>
      </abstract>
      <kwd-group>
                <kwd>Digital pharmacy</kwd>
                <kwd>Artificial intelligence</kwd>
                <kwd>Pharmacy practice</kwd>
                <kwd>Medication safety</kwd>
                <kwd>Human–AI collaboration</kwd>
                <kwd>Clinical decision support</kwd>
              </kwd-group>
    </article-meta>
  </front>
</article>